Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Br J Pharmacol. 2010 Nov;161(5):1122-36. doi: 10.1111/j.1476-5381.2010.00944.x.
µ- and δ-opioid receptors form heteromeric complexes with unique ligand binding and G protein-coupling profiles linked to G protein α z-subunit (Gα(z) ) activation. However, the mechanism of action of agonists and their regulation of the µ-δ receptor heteromer are not well understood.
Competition radioligand binding, cell surface receptor internalization in intact cells, confocal microscopy and receptor immunofluorescence techniques were employed to study the regulation of the µ-δ receptor heteromer in heterologous cells with and without agonist exposure.
Gα(z) enhanced affinity of some agonists at µ-δ receptor heteromers, independent of agonist chemical structure. δ-Opioid agonists displaced µ-agonist binding with high affinity from µ-δ heteromers, but not µ receptor homomers, suggestive of δ-agonists occupying a novel µ-receptor ligand binding pocket within the heteromers. Also, δ-agonists induced internalization of µ-opioid receptors in cells co-expressing µ- and δ-receptors, but not those expressing µ-receptors alone, indicative of µ-δ heteromer internalization. This dose-dependent, Pertussis toxin-resistant and clathrin- and dynamin-dependent effect required agonist occupancy of both µ- and δ-opioid receptors. In contrast to µ-receptor homomers, agonist-induced internalization of µ-δ heteromers persisted following chronic morphine exposure.
The µ-δ receptor heteromer may contain a novel δ-agonist-detected, high-affinity, µ-receptor ligand binding pocket and is regulated differently from the µ-receptor homomer following chronic morphine exposure. Occupancy of both µ- and δ-receptor binding pockets is required for δ-agonist-induced endocytosis of µ-δ receptor heteromers. δ-Opioid agonists target µ-δ receptor heteromers, and thus have a broader pharmacological specificity than previously identified.
μ 型和 δ 型阿片受体与独特的配体结合和 G 蛋白偶联特性形成异源二聚体,与 G 蛋白 αz 亚基(Gα(z))的激活有关。然而,激动剂的作用机制及其对 μ-δ 受体异源二聚体的调节尚不清楚。
采用竞争放射配体结合、完整细胞表面受体内化、共聚焦显微镜和受体免疫荧光技术,研究了在有和没有激动剂暴露的情况下,异源细胞中 μ-δ 受体异源二聚体的调节。
Gα(z)增强了一些激动剂在 μ-δ 受体异源二聚体中的亲和力,而与激动剂的化学结构无关。δ 型阿片受体激动剂以高亲和力从 μ-δ 异源二聚体中置换 μ 型激动剂结合,但不置换 μ 受体同源二聚体,提示 δ 型激动剂占据了异源二聚体中 μ 受体的一个新的配体结合口袋。此外,δ 型激动剂诱导共表达 μ-和 δ-受体的细胞中 μ 型阿片受体内化,但不诱导仅表达 μ 受体的细胞内化,提示 μ-δ 异源二聚体内化。这种剂量依赖性、百日咳毒素抗性、网格蛋白和动力蛋白依赖性效应需要 μ-和 δ-阿片受体的激动剂占据。与 μ 受体同源二聚体不同,慢性吗啡暴露后,激动剂诱导的 μ-δ 异源二聚体内化持续存在。
μ-δ 受体异源二聚体可能包含一个新的 δ-激动剂检测的高亲和力 μ 受体配体结合口袋,并且在慢性吗啡暴露后,其调节方式与 μ 受体同源二聚体不同。需要占据 μ-和 δ-受体的结合口袋,才能引起 δ-激动剂诱导的 μ-δ 受体异源二聚体内化。δ 型阿片受体激动剂靶向 μ-δ 受体异源二聚体,因此具有比以前鉴定的更广泛的药理学特异性。